Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer

Oligometastatic disease in prostate cancer (PCa) is a challenging clinical scenario encountered more frequently with the widespread adoption of PSMA-PET. SBRT aims to defer androgen deprivation and may deliver...

Source: Radiation Oncology - August 1, 2023 Category: Cancer & Oncology Authors: Riche Mohan, A. Kneebone, T. Eade, E. Hsiao, L. Emmett, Christopher Brown, J. Hunter and G. Hruby Tags: Research Source Type: research